Registration

All testing materials provided through this program are for in vitro evaluation use only. Use of any testing materials obtained through this program to determine therapeutic options for patient treatment, or any other diagnostic purpose is prohibited. The Institution is prohibited from charging any patient or third-party payer for any testing materials or including the value of the testing materials on any cost report submitted to any government agency or other third party. The Institution may not transfer any materials provided through this program, including ETEST® AZTREONAM / AVIBACTAM (AZA) panels, to another party or laboratory. The Institution acknowledges that the provision of testing materials through this program are not contingent on, nor intended to serve as an inducement or reward for, any past or future purchases of Pfizer products. Pfizer reserves the right to disclose any transfer for value provided in connection with this program in accordance with state and federal transparency laws. This program may be discontinued at any time.

The testing materials provided through this program have been developed and manufactured by bioMerieux, and are currently labeled for Research Use only and are not authorized for diagnosis purposes . All questions or comments for any presentation or publication (including any written, oral, or electronic manuscript, abstract, presentation, or other publication) related to the testing materials ETEST RUO assays should be addressed to bioMerieux ‘s head of Medical Affairs at bioMerieux at the following email address: bioMerieux.Medical.Affairs@biomerieux.com

The Institution shall comply with all laws, regulations, and rules applicable to its operations and to its participation to this program, and will obtain, if applicable, relevant, and necessary authorization from Ethics Committees or any relevant authorities, as applicable.

Institution certifies that neither they, nor any of their management or any other employees or independent contractors or agents who will have any involvement in the program, are excluded from participation in any government healthcare program, debarred from or under any other national or relevant procurement or non-procurement program; further, Institution represents that it is not aware of any pending or potential action(s) (including criminal actions) against it or its employees or independent contractors or agents which would give rise to any such ineligibility. Your Institution shall notify Pfizer immediately upon becoming aware of any pending or final action in any of these areas.